Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Recruiting · NCT06334575 · Registry updated 2026-07-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 4 | 2026-07-20 | NCT06334575 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Maria Joyera Rodríguez | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | 1 |
| Clínic Barcelona | Barcelona | Spain | 1 |
| Imperial College London | London | United Kingdom | 12 |
| Philips University of Marburg | Marburg | Germany | 1 |
| Son Espases | Palma de Mallorca | Spain | 1 |
| University of Leicester | Leicester | United Kingdom | 4 |